Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study.
Yuta SatoManabu FutamuraYoshihiro TanakaHiroshi TsuchiyaMasahiro FukadaToshiya HigashiItaru YasufukuRyuichi AsaiJesse Yu TajimaShigeru KiyamaHideyuki HatakeyamaMasayo MorishitaTakaaki HirotsuEric di LuccioTakuma IshiharaNobuhisa MatsuhashiKazuhiro YoshidaPublished in: Cancers (2023)
Index reduction score using N-NOSE screening may reflect the efficacy of chemotherapy for esophageal cancer patients. A large-scale prospective study at multiple centers is desired in the future.